Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Definitions

Low-dose GLP-1 versus microdosing

Released: · Last reviewed:

A labeled starter dose, a reduced maintenance dose, and a provider 'microdose' are three different things.

'Low-dose' and 'microdose' are not the same thing, and neither is a labeled starter dose. A labeled starter dose is defined by the FDA product; a reduced maintenance dose sits below the maximum studied dose; a provider 'microdose' is a marketing term with no fixed value. This page draws the lines the marketing blurs.

Distinguishing the concepts (2026-07-20)
ConceptKindEvidence
FDA-labeled starter doselabelDefined in FDA labeling; efficacy/safety established for the approved product only.
Lower-than-maintenance dosestrategyNot a standardized clinical protocol; outcomes at sub-maintenance doses are not established for weight management.
Reduced maintenance dosestrategySome trial evidence exists for specific reduced maintenance doses (e.g., SURMOUNT-MAINTAIN 5 mg arm); does not generalize to arbitrary 'microdoses'.
Slower titrationstrategyCommonly used clinically; not the same as a fixed low 'microdose'; limited comparative trial evidence.
Less-frequent dosingstrategyHypothesis-generating case series and pharmacokinetic modeling only; not established for weight outcomes.
Provider-defined 'microdose'commercialCommercial label, not a clinical protocol; each provider's definition must be read individually.

What the evidence shows

  • Reduced maintenance dosing has specific trial support in named studies.
  • Labeled starter doses are defined and studied within the approved product.

What the evidence does not show

  • That a provider 'microdose' equals any studied dose.
  • That 'low-dose' and 'microdose' can be used interchangeably without changing the evidence.

Frequently asked questions

What dose counts as a GLP-1 microdose?

There is no agreed microdose, because each program writes its own definition: as of November 8, 2026, Noom's compounded semaglutide chart runs from 0.2 mg to a 0.6 mg weekly maximum, Lemonaid caps microdoses at 25% of the standard maintenance dose, and NexLife's microdose pages print no dose at all. For scale, Wegovy starts at 0.25 mg a week and is maintained at 1.7 or 2.4 mg, while Zepbound starts at 2.5 mg with maintenance at 5, 10 or 15 mg. Compounded vials are measured in units that depend on concentration, so confirm the milligrams with your prescriber.

Is a microdose just a low dose?

Not necessarily. 'Low-dose' often refers to a labeled or reduced dose with clinical basis; 'microdose' is an unstandardized marketing term that may mean a much smaller, unstudied amount.

Is either FDA approved?

Approved products have specific labeled doses. Compounded low-dose or microdose programs are not FDA approved.

Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.